Alerts
PDF
Other content recommended for you
- Financial interests of patient organisations contributing to technology assessment at England’s National Institute for Health and Care Excellence: policy review
- Exposing drug industry funding of UK patient organisations
- Cancer patients’ organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries
- Is the international regulation of medical complicity with torture largely window dressing? The case of Israel and the lessons of a 12-year medical ethical appeal
- Patient–physician collaboration in rheumatology: a necessity
- 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
- Access to investigational medicinal products for minors in Europe: ethical and regulatory issues in negotiating children's access to investigational medicines
- Medical complications and deaths in 21 and 56 km road race runners: a 4-year prospective study in 65 865 runners—SAFER study I
- The European Statements of Hospital Pharmacy: the patient and healthcare perspective
- Patient and caregiver priorities in the transition from hospital to home: results from province-wide group concept mapping